OmniAb (OABI) Depreciation & Amortization (CF) (2022 - 2026)

OmniAb's (OABI) quarterly Depreciation & Amortization (CF) came in at $606000.0 in Q1 2026, down 87.22% year-on-year from $4.7 million in Q1 2025, and down 92.14% on a QoQ basis from $7.7 million in Q4 2025.

OmniAb (OABI) Depreciation & Amortization (CF) (2022 - 2026) Analysis & Trends

OmniAb (OABI) has 5 years of Depreciation & Amortization (CF) data on file, last reported at $606000.0 in Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 87.22% year-over-year to $606000.0 in Q1 2026; TTM through Mar 2026 was $17.6 million, a 24.64% decrease from a year earlier, with the FY2025 full-year figure at $21.8 million, down 7.76% from the prior year.
  • Depreciation & Amortization (CF) for Q1 2026 stood at $606000.0, down from $7.7 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for OABI reached as high as $7.7 million in Q4 2025 and fell as low as $606000.0 in Q1 2026.
  • Historically, Depreciation & Amortization (CF) has averaged $4.9 million across 5 years, with a median of $4.8 million in 2023.
  • Across the five-year window, Depreciation & Amortization (CF) surged 54.15% in 2024 and plunged 87.22% in 2026, its largest moves.
  • Year by year, Depreciation & Amortization (CF) stood at $4.8 million in 2022, then grew by 2.37% to $4.9 million in 2023, then soared by 54.15% to $7.6 million in 2024, then rose by 1.33% to $7.7 million in 2025, then sank by 92.14% to $606000.0 in 2026.
  • Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $606000.0 in Q1 2026, $7.7 million in Q4 2025, and $4.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 196,658.72
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 41.14 Mn
4 NuCana 279.75 Bn 279.75 Bn - 91,781.47
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 55.90 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 123.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.20 Mn
10 OmniAb 261.62 Mn 212.55 Mn 14.41 Mn 606,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 606,000.00
Mar 31, 2026 606,000.00
Dec 31, 2025 7.71 Mn
Dec 31, 2025 7.71 Mn
Sep 30, 2025 4.66 Mn
Sep 30, 2025 4.66 Mn
Jun 30, 2025 4.65 Mn
Jun 30, 2025 4.65 Mn
Mar 31, 2025 4.74 Mn
Mar 31, 2025 4.74 Mn
Dec 31, 2024 7.61 Mn
Dec 31, 2024 7.61 Mn
Sep 30, 2024 4.93 Mn
Sep 30, 2024 4.93 Mn
Jun 30, 2024 6.10 Mn
Jun 30, 2024 6.10 Mn
Mar 31, 2024 4.95 Mn
Mar 31, 2024 4.95 Mn
Dec 31, 2023 4.93 Mn
Dec 31, 2023 4.93 Mn